JP2010263906A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010263906A5 JP2010263906A5 JP2010155397A JP2010155397A JP2010263906A5 JP 2010263906 A5 JP2010263906 A5 JP 2010263906A5 JP 2010155397 A JP2010155397 A JP 2010155397A JP 2010155397 A JP2010155397 A JP 2010155397A JP 2010263906 A5 JP2010263906 A5 JP 2010263906A5
- Authority
- JP
- Japan
- Prior art keywords
- polymorphism
- residue
- occurrence
- gene encoding
- encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 claims 131
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 58
- 208000035475 disorder Diseases 0.000 claims 57
- 125000003729 nucleotide group Chemical group 0.000 claims 52
- 238000000034 method Methods 0.000 claims 39
- 108091034117 Oligonucleotide Proteins 0.000 claims 30
- 108020004705 Codon Proteins 0.000 claims 24
- 125000000539 amino acid group Chemical group 0.000 claims 22
- 102000019197 Superoxide Dismutase Human genes 0.000 claims 20
- 108010012715 Superoxide dismutase Proteins 0.000 claims 20
- 230000001086 cytosolic effect Effects 0.000 claims 18
- 230000002438 mitochondrial effect Effects 0.000 claims 18
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims 17
- 101710112368 Glutathione S-transferase P 1 Proteins 0.000 claims 14
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 claims 14
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 claims 14
- 108700026244 Open Reading Frames Proteins 0.000 claims 14
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 claims 13
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims 13
- 102000005486 Epoxide hydrolase Human genes 0.000 claims 13
- 108020002908 Epoxide hydrolase Proteins 0.000 claims 13
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 13
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 13
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims 12
- 108010053835 Catalase Proteins 0.000 claims 12
- 102100030943 Glutathione S-transferase P Human genes 0.000 claims 12
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 12
- 102000054765 polymorphisms of proteins Human genes 0.000 claims 12
- 102000008299 Nitric Oxide Synthase Human genes 0.000 claims 11
- 108010021487 Nitric Oxide Synthase Proteins 0.000 claims 11
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 9
- 108020000284 NAD(P)H dehydrogenase (quinone) Proteins 0.000 claims 8
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims 8
- 238000000137 annealing Methods 0.000 claims 8
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims 8
- 102000016938 Catalase Human genes 0.000 claims 7
- 235000001014 amino acid Nutrition 0.000 claims 7
- 229940024606 amino acid Drugs 0.000 claims 7
- 150000001413 amino acids Chemical class 0.000 claims 7
- 108020004707 nucleic acids Proteins 0.000 claims 7
- 102000039446 nucleic acids Human genes 0.000 claims 7
- 150000007523 nucleic acids Chemical class 0.000 claims 7
- 239000002773 nucleotide Substances 0.000 claims 7
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 6
- 235000016709 nutrition Nutrition 0.000 claims 6
- 239000004474 valine Substances 0.000 claims 6
- 101710157142 2-methylene-furan-3-one reductase Proteins 0.000 claims 5
- 101710189291 Quinone oxidoreductase Proteins 0.000 claims 5
- 102100034576 Quinone oxidoreductase Human genes 0.000 claims 5
- 230000000295 complement effect Effects 0.000 claims 5
- 230000036559 skin health Effects 0.000 claims 5
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 4
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- 230000018109 developmental process Effects 0.000 claims 4
- 229960000310 isoleucine Drugs 0.000 claims 4
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 4
- 108700041153 Filaggrin Proteins Proteins 0.000 claims 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 3
- 208000017520 skin disease Diseases 0.000 claims 3
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 3
- 108020005029 5' Flanking Region Proteins 0.000 claims 2
- 102000004328 Cytochrome P-450 CYP3A Human genes 0.000 claims 2
- 108010081668 Cytochrome P-450 CYP3A Proteins 0.000 claims 2
- 102000006587 Glutathione peroxidase Human genes 0.000 claims 2
- 108700016172 Glutathione peroxidases Proteins 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- 235000018417 cysteine Nutrition 0.000 claims 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000011156 evaluation Methods 0.000 claims 2
- 238000009396 hybridization Methods 0.000 claims 2
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 claims 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 2
- 229940113082 thymine Drugs 0.000 claims 2
- 229930024421 Adenine Natural products 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- 241001024304 Mino Species 0.000 claims 1
- 108010007843 NADH oxidase Proteins 0.000 claims 1
- 108010002998 NADPH Oxidases Proteins 0.000 claims 1
- 102000004722 NADPH Oxidases Human genes 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229960000643 adenine Drugs 0.000 claims 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000001747 exhibiting effect Effects 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 claims 1
- DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims 1
- 239000011814 protection agent Substances 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 claims 1
- 230000006128 skin development Effects 0.000 claims 1
- 239000003009 skin protective agent Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/247,935 US7211383B2 (en) | 2001-04-05 | 2002-09-20 | Kits and methods for assessing skin health |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004538253A Division JP2006513699A (ja) | 2002-09-20 | 2003-09-19 | 皮膚の健康を評価するためのキットおよび方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013161944A Division JP2013240351A (ja) | 2002-09-20 | 2013-08-05 | 皮膚の健康を評価するためのキットおよび方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010263906A JP2010263906A (ja) | 2010-11-25 |
| JP2010263906A5 true JP2010263906A5 (enExample) | 2011-09-29 |
Family
ID=32028981
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004538253A Withdrawn JP2006513699A (ja) | 2002-09-20 | 2003-09-19 | 皮膚の健康を評価するためのキットおよび方法 |
| JP2010155397A Pending JP2010263906A (ja) | 2002-09-20 | 2010-07-08 | 皮膚の健康を評価するためのキットおよび方法 |
| JP2013161944A Pending JP2013240351A (ja) | 2002-09-20 | 2013-08-05 | 皮膚の健康を評価するためのキットおよび方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004538253A Withdrawn JP2006513699A (ja) | 2002-09-20 | 2003-09-19 | 皮膚の健康を評価するためのキットおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013161944A Pending JP2013240351A (ja) | 2002-09-20 | 2013-08-05 | 皮膚の健康を評価するためのキットおよび方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7211383B2 (enExample) |
| EP (1) | EP1581094A4 (enExample) |
| JP (3) | JP2006513699A (enExample) |
| KR (1) | KR20050057525A (enExample) |
| AU (1) | AU2003275038B2 (enExample) |
| CA (1) | CA2499390C (enExample) |
| WO (1) | WO2004026107A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7054758B2 (en) * | 2001-01-30 | 2006-05-30 | Sciona Limited | Computer-assisted means for assessing lifestyle risk factors |
| US20020146698A1 (en) * | 2001-04-05 | 2002-10-10 | Genelink, Inc. | Kits and methods for assessing oxidative stress |
| US7211383B2 (en) * | 2001-04-05 | 2007-05-01 | Genelink, Inc. | Kits and methods for assessing skin health |
| FI20040227L (fi) * | 2004-02-13 | 2005-08-14 | Jurilab Ltd Oy | Menetelmä syövän, sepelvaltimotaudin ja aivohalvauksen riskin havaitsemiseksi |
| CN100412208C (zh) * | 2006-04-07 | 2008-08-20 | 甄二真 | 基于基因多态性的皮肤美容保健方法 |
| WO2009127073A1 (de) * | 2008-04-18 | 2009-10-22 | Gen Sod2 Foundation | Auf ein individuum abgestimmte kosmetikzubereitung und verfahren zu deren herstellung |
| US20100304373A1 (en) * | 2008-08-14 | 2010-12-02 | Ricciardi Robert P | Methods for Assessing the Susceptibility of a Human to Diminished Health and Wellness |
| KR101109043B1 (ko) * | 2008-12-30 | 2012-02-09 | 사회복지법인 삼성생명공익재단 | 각질세포 또는 혈청 유래의 아토피성 피부질환 마커 |
| JP2011115098A (ja) * | 2009-12-04 | 2011-06-16 | Nippon Menaade Keshohin Kk | 加齢による皮膚明度の低下を予測する皮膚評価方法 |
| GB2493141A (en) * | 2011-07-19 | 2013-01-30 | Gene Onyx Ltd | Method of selecting a product using a DNA sample |
| KR101803980B1 (ko) * | 2011-08-03 | 2017-12-04 | 주식회사 엘지생활건강 | 민감성 피부 타입 유전자 다형성 마커 및 이의 용도 |
| GB2497766A (en) * | 2011-12-20 | 2013-06-26 | Gene Onyx Ltd | Snp analysis to determine efficacy of skin care product |
| KR20160075501A (ko) * | 2013-09-25 | 2016-06-29 | 더 프록터 앤드 갬블 캄파니 | 피부 케어 상담을 위한 방법 및 시스템 |
| JP6328903B2 (ja) * | 2013-10-10 | 2018-05-23 | ジェネシスヘルスケア株式会社 | 皮膚関連遺伝子に基づく肌におけるリスク判別システム |
| CN108048423B (zh) * | 2018-01-15 | 2020-05-08 | 江南大学 | 一种催化活性提高的菜豆环氧化物水解酶突变体及其应用 |
| KR102346186B1 (ko) * | 2019-12-23 | 2022-01-03 | 주식회사 테라젠바이오 | 피부 민감 위험도 예측용 바이오마커 및 이의 용도 |
| KR20220137382A (ko) * | 2021-04-02 | 2022-10-12 | 주식회사 엘지생활건강 | 주름 피부 타입 판단용 유전자 다형성 마커 및 이의 용도 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3616923A1 (de) | 1986-05-20 | 1987-11-26 | Nattermann A & Cie | Neue pharmazeutische verwendung von 2-phenyl-1,2-benzisoselenazol-3(2h)-on |
| US6013431A (en) | 1990-02-16 | 2000-01-11 | Molecular Tool, Inc. | Method for determining specific nucleotide variations by primer extension in the presence of mixture of labeled nucleotides and terminators |
| US6004744A (en) | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
| CA2139667C (en) | 1992-07-06 | 2005-03-29 | Spencer B. Farr | Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes |
| US5643623A (en) | 1995-06-07 | 1997-07-01 | Mars Incorporated | Health food product and its uses |
| US6291171B1 (en) | 1995-11-15 | 2001-09-18 | Robert P. Ricciardi | Kit for the non-invasive identification and collection of DNA |
| US5891622A (en) | 1996-09-30 | 1999-04-06 | Oxford Biomedical Research, Inc. | Assessment of oxidative stress in vivo |
| US5955111A (en) | 1996-10-08 | 1999-09-21 | Hartford Hospital | Methods and compositions for inducing production of stress proteins |
| US5920634A (en) * | 1996-11-13 | 1999-07-06 | Chiquette; Grace Rojan | Activatable audio advertising display standard |
| JP3381053B2 (ja) | 1996-11-29 | 2003-02-24 | 日研フード株式会社 | 酸化的ストレス判断解析表 |
| US6133039A (en) | 1998-02-09 | 2000-10-17 | Washinton University | In vivo method for determination of oxidative stress |
| US20020146698A1 (en) | 2001-04-05 | 2002-10-10 | Genelink, Inc. | Kits and methods for assessing oxidative stress |
| EP1386001A4 (en) * | 2001-04-05 | 2005-07-20 | Genelink Inc | KITS AND METHOD FOR ASSESSING OXIDATIVE STRESS |
| US7211383B2 (en) | 2001-04-05 | 2007-05-01 | Genelink, Inc. | Kits and methods for assessing skin health |
-
2002
- 2002-09-20 US US10/247,935 patent/US7211383B2/en not_active Expired - Lifetime
-
2003
- 2003-09-19 CA CA2499390A patent/CA2499390C/en not_active Expired - Fee Related
- 2003-09-19 KR KR1020057004865A patent/KR20050057525A/ko not_active Ceased
- 2003-09-19 AU AU2003275038A patent/AU2003275038B2/en not_active Ceased
- 2003-09-19 WO PCT/US2003/029529 patent/WO2004026107A2/en not_active Ceased
- 2003-09-19 JP JP2004538253A patent/JP2006513699A/ja not_active Withdrawn
- 2003-09-19 EP EP03759308A patent/EP1581094A4/en not_active Withdrawn
-
2007
- 2007-03-30 US US11/731,180 patent/US8313930B2/en not_active Expired - Fee Related
-
2010
- 2010-07-08 JP JP2010155397A patent/JP2010263906A/ja active Pending
-
2012
- 2012-11-05 US US13/668,842 patent/US20130130247A1/en not_active Abandoned
-
2013
- 2013-08-05 JP JP2013161944A patent/JP2013240351A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mengel-From et al. | Human eye colour and HERC2, OCA2 and MATP | |
| US8313930B2 (en) | Kits and methods for assessing skin health | |
| Oka et al. | Current understanding of human genetics and genetic analysis of psoriasis | |
| JP2013240351A5 (enExample) | ||
| US20140066327A1 (en) | Kits and Methods for Assessing Oxidative Stress | |
| AU2002309543B2 (en) | Kits and methods for assessing oxidative stress | |
| CN104152557B (zh) | 基因多态性变异位点早期评估乳腺癌风险的诊断试剂盒 | |
| Babu et al. | Identification of candidate gene–based SSR markers for lysine and tryptophan metabolic pathways in maize (Zea mays) | |
| AU2002309543A1 (en) | Kits and methods for assessing oxidative stress | |
| CN103642921A (zh) | 过氧化氢酶基因标签单核苷酸多态性位点的挑选、检测及其应用 | |
| JP2009511026A (ja) | 血栓塞栓性及び冠状動脈性心疾患の診断方法 | |
| KR20110021095A (ko) | 성별 판별 및／또는 개체 식별용 ｓｎｐ 마커 | |
| Süzen et al. | Molecular analysis of δ-aminolevulinic acid dehydratase (ALAD) gene polymorphism in a Turkish population | |
| KR102860441B1 (ko) | 저hdl 콜레스테롤 혈증 판정용 snp 마커 및 이의 용도 | |
| JP2020178586A (ja) | 接触性皮膚炎のリスクを判定する方法 | |
| JP5002746B2 (ja) | 抗うつ薬に対する反応性予測に有用な遺伝子多型 | |
| Ibrahim et al. | Association of Arginase I Gene Polymorphism with the Risk of Atherosclerosis in a Sample of Iraqi Patients. | |
| Kastelic et al. | Single multiplex system of twelve SNPs: validation and implementation for association of SNPs with human eye and hair color | |
| WO2022073259A1 (zh) | 基于cox10基因插入缺失多态性位点的心源性猝死易感性检测试剂盒 | |
| CN117737247A (zh) | 一种检测肝母细胞瘤易感性的引物组、试剂盒及其应用 | |
| Kim et al. | Genomic alteration of bisphenol A treatment in the testis of mice | |
| JP2020178536A (ja) | アレルギー性結膜炎のリスクを判定する方法 | |
| Fatjó-Vilas et al. | 276–Genetic differences between early and late onset psychosis identified by whole genome comparative genomic hybridization arrays | |
| KR20170124006A (ko) | 항산화능의 예측 방법 |